Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2483 (LINC02483) is a long intergenic non-coding RNA, which, by definition, is a transcript longer than 200 nucleotides that does not encode a protein and is situated between known protein-coding genes[1][7]. LincRNAs as a biological class are transcribed by RNA polymerase II and can play diverse roles in gene expression regulation, often acting through modulation of chromatin architecture, transcription factors, or epigenetic marks[5][7]. Although many lincRNAs have been implicated in cellular regulation and human diseases such as cancer, the individual function and disease associations of LINC02483 remain undetermined. There is no evidence this transcript acts as a drug target, a clinical biomarker, or a known cause of pathology. Its annotation is recognized in gene databases and its status as a non-coding RNA is well established[1]. If more specific functional or disease-related data for LINC02483 is discovered, these entries may be updated. Current evidence supports its classification as a non-protein coding regulatory RNA with uncharacterized function and no documented direct therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2483 (LINC02483).